ProDERM RCT IVIG in Dermatomyositis ⭐️improved TIS scores compared to pbo ⭐️common AE: headaches, pyrexia, nausea ⭐️serious AE: PE, CVA, DVT ⭐️approved in Europe, pending FDA Abs#OP0008 #EULAR2021 @RheumNow